Product Information

TREXALL 5 MG TABLET is a brand (anda) product labeled by Teva Women's Health, Inc., priced at $24.0884 per EA under NDC 51285036601. Its NADAC has been published 75 times since Jan 22, 2025.

The High Outlier badge above means this manufacturer's average price in the Methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TREXALL 5 MG TABLET

Methotrexate
$24.0884per EA
High Outlier

Strength

5 mg/1

NDC

51285036601

Classification

Brand (ANDA)

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040385

On Market Since

5/3/2001

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price Statistics

The NADAC for TREXALL 5 MG TABLET has been published 75 times since Jan 22, 2025, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.

Current price$24.0884 per EA
All-time high$24.0884 (Jun 24, 2026)
All-time low$22.0187 (Jan 22, 2025)
52-week high$24.0884
52-week low$22.0187
Median price$22.0187
Average price$22.7086
Largest weekly change+9.4% (Jan 7, 2026)
Weeks tracked75
Tracking sinceJan 22, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+9.4%

1Y

+9.4%

3Y

N/A

5Y

N/A

All

+9.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methotrexate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of TREXALL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TREXALL 5 MG TABLET, manufactured by Teva Women's Health, Inc., is $24.0884 per EA (NDC 51285036601), effective Jun 24, 2026.

How has the price of TREXALL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TREXALL 5 MG TABLET has risen 9.4%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.

What are the highest and lowest recorded NADAC prices for TREXALL 5 MG TABLET?

Since Jan 22, 2025, the NADAC for TREXALL 5 MG TABLET has ranged from a low of $22.0187 (Jan 22, 2025) to a high of $24.0884 (Jun 24, 2026), with a median of $22.0187 per EA.

Are there cheaper alternatives to TREXALL 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TREXALL 5 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures TREXALL 5 MG TABLET?

TREXALL 5 MG TABLET (NDC 51285036601) is labeled by Teva Women's Health, Inc., and CMS classifies it as a brand (anda) product.

Related Drugs

Same classification

No related drugs found.